The omeprazole global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Omeprazole Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size –
The omeprazole market size has grown strongly in recent years. It will grow from $2.17 billion in 2023 to $2.34 billion in 2024 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to reimbursement policies, transition of patients and healthcare providers from H2 blockers to proton pump inhibitors, educational campaigns raising awareness about the benefits of omeprazole therapy, Government spending on healthcare infrastructure and services, and health literacy initiatives.
The omeprazole market size is expected to see strong growth in the next few years. It will grow to $3.15 billion in 2028 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to government interventions to control drug prices affecting profitability, disruptions in the pharmaceutical supply chain affecting omeprazole availability and pricing, personalized treatment approaches, increasing consumer awareness and preference for self-care products and changes in disease patterns and prevalence rates affecting the demand for omeprazole. Major trends in the forecast period include development of gene editing technologies, advancements in pharmacogenomics, adoption of telemedicine, integration of digital health technologies and expansion of online platforms.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/omeprazole-global-market-report
Scope Of Omeprazole Market
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Omeprazole Market Overview
Market Drivers –
The increased incidence of gastric cancers is expected to propel the growth of the omeprazole market going forward. Gastric cancers refer to malignancies that originate in the lining of the stomach. The increased incidence of gastric cancers is due to chronic helicobacter pylori infection, heavy alcohol consumption, genetic predisposition, chronic gastritis, obesity, and geographical variations in prevalence. Omeprazole, a proton pump inhibitor, helps manage gastric cancers by reducing stomach acid production, which can alleviate symptoms, improve quality of life, and support healing ulcers or lesions in the stomach lining. For instance, in January 2023, according to the American Cancer Society (ACS), a US-based health organization dedicated to eliminating cancer, gastrointestinal cancers increased by 3.18% to 348,840 compared to 338,090 in 2021 in the United States. Therefore, the increased incidence of gastric cancers is driving the omeprazole market.
Market Trends –
Major companies operating in the omeprazole market are developing ready-to-use liquid formulations to enhance patient convenience and compliance, particularly for those who have difficulty swallowing tablets or capsules. Ready-to-use liquid formulations of omeprazole help to improve patient compliance, enhance convenience, provide accurate dosing, offer a faster onset of action, and ensure enhanced medication stability. For instance, in February 2024, Alkaloid AD, a North Macedonia-based pharmaceutical manufacturing company, launched liquid Omeprazole. It is the first ready-to-use liquid Omeprazole for reflux esophagitis and GERD patients unable to swallow tablets, and it features a dual-chamber package. This innovation provides a more practical and accessible treatment option for patients who have difficulty in swallowing tablets or capsules, such as young children, adult patients with dysphagia, and those with gastric feeding tubes or geriatric patients. The company has obtained the first international patent for a value-added medicine (VAM) for this product and has received marketing authorizations for the Macedonian and UK markets.
The omeprazole market covered in this report is segmented –
1) By Dosage Form: Capsule, Powder, Tablet
2) By Indication: Duodenal Ulcer, Gastric Ulcer, Gastroesophageal Reflux Disease, Erosive Esophagitis, Other Indications
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Get an inside scoop of the omeprazole market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=16495&type=smp
Regional Insights –
North America was the largest region in the omeprazole market in 2023. The regions covered in the omeprazole market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Key Companies –
Major companies operating in the omeprazole market are <b>Pfizer Inc., AstraZeneca plc, Novartis AG, Viatris Inc., Teva Pharmaceutical Industries Ltd., Sandoz Group AG, Fresenius Kabi, Macleods Pharmaceuticals Pvt Ltd., Perrigo Company plc, Sun Pharmaceutical Industries Ltd., Intas Pharmaceuticals Ltd., Aurobindo Pharma, Dr. Reddy’s Laboratories, Cipla, Apotex Inc., Amneal Pharmaceuticals, Lupin Limited, Glenmark Pharmaceuticals Ltd., Alkem Laboratories Ltd., Torrent Pharmaceuticals, Jubilant Generics Limited, Accord Healthcare, Hetero Healthcare Limited, Zydus Cadila, Ranbaxy Laboratories Limited</b>
Table of Contents
1. Executive Summary
2. Omeprazole Market Report Structure
3. Omeprazole Market Trends And Strategies
4. Omeprazole Market – Macro Economic Scenario
5. Omeprazole Market Size And Growth
…..
27. Omeprazole Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Explore the trending research reports from TBRC:
https://topprnews.com/property-and-casualty-insurance-software-market-outlook/
https://topprnews.com/saturating-kraft-paper-market-trends/
https://topprnews.com/global-supplementary-cementitious-materials-market-analysis/
https://goodprnews.com/property-and-casualty-insurance-software-market-size/
https://goodprnews.com/saturating-kraft-paper-market-size/
https://goodprnews.com/global-supplementary-cementitious-materials-market/
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
